These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4604487)

  • 21. Fosfomycin and plasmidic resistance.
    Baquero F; López-Brea M; Valls A; Cañedo T
    Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic.
    Oliva B; Maiese WM; Greenstein M; Borders DB; Chopra I
    J Antimicrob Chemother; 1993 Dec; 32(6):817-30. PubMed ID: 7511579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Existence of the bound form of prolipoprotein in Escherichia coli B cells treated with globomycin.
    Inukai M; Takeuchi M; Shimizu K; Arai M
    J Bacteriol; 1979 Dec; 140(3):1098-101. PubMed ID: 391799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of Escherichia coli to viral nucleic acid. IV. Transfection of phage DNA to mutant thermosensitive in wall synthesis.
    Taketo A; Hayashi A; Kuno S
    J Biochem; 1972 Mar; 71(3):513-8. PubMed ID: 4556023
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mechanism of fosfomycin-resistance in clinical isolates].
    O'Hara K; Hashimoto H
    Jpn J Antibiot; 1996 Jun; 49(6):533-43. PubMed ID: 8776629
    [No Abstract]   [Full Text] [Related]  

  • 26. [Activation of phosphonomycin by gamma-globulin].
    Raab W; Windisch J
    Arzneimittelforschung; 1973 Aug; 23(8):1029-30. PubMed ID: 4128970
    [No Abstract]   [Full Text] [Related]  

  • 27. Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
    Lucas AE; Ito R; Mustapha MM; McElheny CL; Mettus RT; Bowler SL; Kantz SF; Pacey MP; Pasculle AW; Cooper VS; Doi Y
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29093108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptidoglycan synthetic enzyme activities of highly purified penicillin-binding protein 3 in Escherichia coli: a septum-forming reaction sequence.
    Ishino F; Matsuhashi M
    Biochem Biophys Res Commun; 1981 Aug; 101(3):905-11. PubMed ID: 7030331
    [No Abstract]   [Full Text] [Related]  

  • 29. Coumermycin A1: A preferential inhibitor of replicative DNA synthesis in Escherichia coli. I. In vivo characterization.
    Ryan MJ
    Biochemistry; 1976 Aug; 15(17):3769-77. PubMed ID: 782522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between bacterial resistance to antibiotics and to the bacteriophage ZAR2].
    Wilckens R; García-Quintana H
    Zentralbl Veterinarmed B; 1981; 28(5):371-7. PubMed ID: 7034409
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of action of negamycin in Escherichia coli K12. I. Inhibition of initiation of protein synthesis.
    Mizuno S; Nitta K; Umezawa H
    Jpn J Antibiot; 1970 Dec; 23(6):581-8. PubMed ID: 4923582
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of a cinodine-resistant mutant of Escherichia coli.
    Osburne MS
    J Antibiot (Tokyo); 1995 Nov; 48(11):1359-61. PubMed ID: 8557583
    [No Abstract]   [Full Text] [Related]  

  • 33. Polymerization by transglycosylation in the biosynthesis of the peptidoglycan of Escherichia coli K 12 and its inhibition by antibiotics.
    Van Heijenoort Y; Derrien M; Van Heijenoort J
    FEBS Lett; 1978 May; 89(1):141-4. PubMed ID: 350621
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug dependence and phenotype masking in streptomycin dependent and paromomycin dependent mutants of Escherichia coli.
    Quesnel LB; York P; Skinner VM
    Microbios; 1971 Sep; 4(14):97-107. PubMed ID: 4949967
    [No Abstract]   [Full Text] [Related]  

  • 35. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular insights into fosfomycin resistance in Escherichia coli.
    Ballestero-Téllez M; Docobo-Pérez F; Portillo-Calderón I; Rodríguez-Martínez JM; Racero L; Ramos-Guelfo MS; Blázquez J; Rodríguez-Baño J; Pascual A
    J Antimicrob Chemother; 2017 May; 72(5):1303-1309. PubMed ID: 28093485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of glucose-6-phosphate and inorganic phosphate on the resistance of Klebsiella species and E. coli towards fosfomycin (author's transl)].
    Hirschl A; Rotter M
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):461-9. PubMed ID: 396739
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanisms of resistance in Escherichia coli to the sideromycin antibiotic no. 216: isolation and characterization of the resistant mutants.
    Miyakawa S; Noto T; Okazaki H
    Microbiol Immunol; 1982; 26(10):885-95. PubMed ID: 6761556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of phage formation in lysogenic Escherichia coli by myxin.
    Lesley SM; Behki RM
    J Gen Microbiol; 1972 Jun; 71(1):195-7. PubMed ID: 4556973
    [No Abstract]   [Full Text] [Related]  

  • 40. Alteration of ribosomal protein L5 in a thiopeptin-resistant mutant of Escherichia coli.
    Liou YF; Yoshikawa M; Tanaka N
    Biochem Biophys Res Commun; 1975 Aug; 65(3):1096-101. PubMed ID: 1098662
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.